Literature DB >> 12577301

G1 tetraploidy checkpoint and the suppression of tumorigenesis.

Robert L Margolis1, Olivier D Lohez, Paul R Andreassen.   

Abstract

Checkpoints suppress improper cell cycle progression to ensure that cells maintain the integrity of their genome. During mitosis, a metaphase checkpoint requires the integration of all chromosomes into a metaphase array in the mitotic spindle prior to mitotic exit. Still, mitotic errors occur in mammalian cells with a relatively high frequency. Metaphase represents the last point of control in mitosis. Once the cell commits to anaphase there are no checkpoints to sense segregation defects. In this context, we will explore our recent finding that non-transformed mammalian cells have a checkpoint that acts subsequent to mitotic errors to block the proliferation of cells that have entered G1 with tetraploid status. This arrest is dependent upon both p53 and pRb, and may represent an important function of both p53 and pRb as tumor suppressors. Further, we discuss the possibility that this mechanism may similarly impose G1 arrest in cells that become aneuploid through errors in mitosis. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12577301     DOI: 10.1002/jcb.10411

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  73 in total

1.  Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification.

Authors:  Rozita Bagheri-Yarmand; Anna Biernacka; Kelly K Hunt; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

Review 2.  Illicit survival of cancer cells during polyploidization and depolyploidization.

Authors:  I Vitale; L Galluzzi; L Senovilla; A Criollo; M Jemaà; M Castedo; G Kroemer
Journal:  Cell Death Differ       Date:  2010-11-12       Impact factor: 15.828

3.  Establishment and characterization of fin cell lines from diploid, triploid, and tetraploid oriental weatherfish (Misgurnus anguillicaudatus).

Authors:  Xia Li; Chen Ma; Yan-Jie Qin; Ya-Juan Li; Di Wu; Li-Wen Bai; Ai-Jun Pei
Journal:  Fish Physiol Biochem       Date:  2015-02-27       Impact factor: 2.794

4.  Different cell cycle responses of wound healing protagonists to transient in vitro hypoxia.

Authors:  Martin Oberringer; Martina Jennewein; Sandra E Motsch; Tim Pohlemann; Andreas Seekamp
Journal:  Histochem Cell Biol       Date:  2005-05-24       Impact factor: 4.304

5.  Hzf, a p53-responsive gene, regulates maintenance of the G2 phase checkpoint induced by DNA damage.

Authors:  Masataka Sugimoto; Adam Gromley; Charles J Sherr
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

6.  Generating chromosome instability through the simultaneous deletion of Mad2 and p53.

Authors:  Aurora A Burds; Annegret Schulze Lutum; Peter K Sorger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-29       Impact factor: 11.205

7.  Hepatocytes with extensive telomere deprotection and fusion remain viable and regenerate liver mass through endoreduplication.

Authors:  Eros Lazzerini Denchi; Giulia Celli; Titia de Lange
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

8.  An inhibitor of the kinesin spindle protein activates the intrinsic apoptotic pathway independently of p53 and de novo protein synthesis.

Authors:  Weikang Tao; Victoria J South; Ronald E Diehl; Joseph P Davide; Laura Sepp-Lorenzino; Mark E Fraley; Kenneth L Arrington; Robert B Lobell
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

9.  Abrogation of the postmitotic checkpoint contributes to polyploidization in human papillomavirus E7-expressing cells.

Authors:  Susan A Heilman; Joshua J Nordberg; Yingwang Liu; Greenfield Sluder; Jason J Chen
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

Review 10.  Mitosis as an anti-cancer drug target.

Authors:  Anna-Leena Salmela; Marko J Kallio
Journal:  Chromosoma       Date:  2013-06-18       Impact factor: 4.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.